Centiva Capital’s AngioDynamics ANGO Stock Holding History

Centiva Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-30,996	Closed	-$307K	–	1083
2025 Q2	$307K	Buy	30,996 +5,890	+23%	+$57.7K	0.01%	1181
2025 Q1	$236K	Buy	+25,106	New	+$264K	0.01%	1214
2023 Q4	–	Sell	-38,316	Closed	-$280K	–	1769
2023 Q3	$280K	Buy	+38,316	New	+$319K	0.01%	1213

Other funds holding ANGO

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $295M AUM 19.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Centiva Capital's ANGO Position: Q3 2025 in Review

Centiva Capital sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 30,996 shares — an estimated $307K sold.

Centiva Capital first reported a position in ANGO in Q3 2023 and held it in 3 quarters. The position peaked at $307K in Q2 2025. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

Centiva Capital reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
Centiva Capital sold 30,996 AngioDynamics shares in Q3 2025, an estimated $307K.
Centiva Capital first reported a position in AngioDynamics in Q3 2023 and held it in 3 quarters.
Centiva Capital's AngioDynamics position peaked at $307K in Q2 2025.
144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.